News
Pfizer (NYSE:PFE) develops and sells biopharmaceutical products, including vaccines, treatments for infectious diseases, ...
The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US ...
Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...
In the second quarter, Pfizer reported adjusted diluted earnings per share of $0.78 on revenue of nearly $14.7 billion. Both ...
Shares in the data-software company were up 7.8% Tuesday after it posted higher quarterly results and [boosted its annual ...
One of the most appealing features of Pfizer's stock is its dividend. The payout recently yielded a hefty 7.4% -- and it's ...
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
Vietnam Investment Review on MSN2h
Pfizer Romania Named Best Place to Work for 202586% align with Pfizer's commitment to social responsibility 83% rate HR practices as people-focused 94% alignment with best ...
Second-quarter adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, beating expectations.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results